Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2024 SABCS
Thematic Newsreels
2024 ASH Annual Meeting
RSNA 2024 Annual Meeting
2024 JADPRO Live
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
The ASCO Post Roundtable Series
present case-based, tumor-specific discussions on the latest developments in cancer care. Join key experts in oncology as they discuss the management of challenging clinical scenarios in oncology.
Personalizing Therapy for Myelofibrosis
Clinical Perspectives on KRAS-Mutant NSCLC
First-Line Immunotherapy for Metastatic NSCLC Special Populations and Unmet Needs
Next-Generation Therapies for Metastatic HR-Positive Breast Cancer
Immunotherapy Strategies for Hepatobiliary Cancers
ALK-Positive Metastatic NSCLC: Where Are We Now
Overcoming Platinum Resistance in Ovarian Cancer
Treatment Strategies for Transplant-Ineligible Relapsed/Refractory DLBCL
Treatment Options for Relapsed Refractory Follicular Lymphoma What Comes Next?
Later-Line Considerations in Relapsed Refractory Renal Cell Carcinoma
Addressing Unmet Needs in Myelofibrosis
Optimizing Outcomes for Patients With Locally Advanced and Metastatic NSCLC
Targeting Endocrine Resistance in HR-Positive/HER2-Negative Metastatic Breast Cancer
Clinical Considerations in the Treatment of Metastatic ROS1 Fusion–Positive NSCLC
New Directions in Nonmetastatic Non–Small Cell Lung Cancer
Evolving Skin Cancer Management
Updates in Early-Stage Breast Cancer
Ovarian Function Suppression in Breast Cancer
New Directions in Metastatic Colorectal Cancer
Novel Therapies for Advanced Breast Cancer
Clinical Advances in Diffuse Large B-Cell Lymphoma
Treatment Considerations in Renal Cell Carcinoma
Updates in Myeloproliferative Neoplasms
Clinical Advances in Mantle Cell Lymphoma
Advances in Follicular Lymphoma
Novel Hormonal Therapies for Prostate Cancer
The Evolving Treatment Landscape for Colorectal Cancer
Clinical Considerations in Chronic Graft-vs-Host Disease
Updates in Melanoma
Updates in Hepatobiliary Cancer
Updates in Renal Cell Carcinoma
Updates in Colorectal Cancer
Updates in HER2-Positive Breast Cancer
Updates in Lymphoma
Updates in Prostate Cancer (1)
Updates in Acute Myeloid Leukemia
Updates in Lung Cancer
Updates in Breast Cancer
Updates in Prostate Cancer
Updates in Gynecologic Oncology
Appropriate Management of Challenging Cases in Lung Cancer
Appropriate Management of Challenging Cases in Myeloma and Lymphoma
Advertisement
Advertisement
Jan
03
Today In Oncology
Most Patients With Intermediate-Risk Breast Cancer May Safely Avoid Chest Wall Irradiation After Mastectomy
De-escalated Neoadjuvant Combination Therapy for HER2-Positive Early Breast Cancer
Learning From the ZEST Trial in Using ctDNA to Predict Breast Cancer Recurrence
Anthracyclines Plus Taxane-Based Chemotherapy for Certain Patients at High Risk for Breast Cancer Recurrence
BRCA-Mutation Carriers With Prior Diagnosis of Early-Onset Breast Cancer May Benefit From Risk-Reducing Surgery
View More
Advertisement